Pluxee in the news

Pluxee's stock remained stable today on the Paris Stock Exchange, closing at 15.710€ with low trading volume, though it has seen declines over the past week and year.

Pluxee's stock saw a marginal increase in its latest trading session despite recent weekly and annual declines, with low trading volume.

Pluxee's stock dipped by 2.49% to 15.66 \u20ac, re-testing a resistance level, though it maintains a strong uptrend over the last three months.

Pluxee's stock experienced a 2.49% dip, trading at "15.66 , but maintains a strong upward trend with significant monthly and quarterly gains.

Pluxee's stock surged 39% in three months, breaking resistance at €16.14, driven by strong technical indicators despite an overbought RSI and an overall negative annual performance.

BFM Bourse advises active investors to buy Pluxee stock due to a confirmed bullish trend and positive technical indicators.

This half-year report details Pluxee N.V.'s liquidity contract activities with BNP Paribas for the first half of 2026, including share transactions and a suspension period due to a share buyback program.

Morgan Stanley analysts state that regulatory risks are overly priced into Pluxee and Edenred shares, making their valuations attractive despite potential downsides.

Pluxee's third-quarter organic sales dropped less than expected, driven by new client wins despite a regulatory cap in Brazil.

A strategic partnership has been formed to launch the 'EmpowerHer' program in Tunisia to foster economic inclusion and entrepreneurship for vulnerable populations.

The CEO of Pluxee Brazil has stepped down, with the Chief Product Officer taking over the role temporarily.

Pluxee's Chilean subsidiary is facing a lawsuit from the Chilean Competition Authority regarding alleged anticompetitive practices in the employee benefits sector from 2013 to 2021.

Chilean antitrust authorities are suing a Pluxee subsidiary over alleged anticompetitive behavior in the employee benefits market.

Pluxee is facing a lawsuit from Chile's competition authority regarding alleged anti-competitive practices in the employee benefits market between 2013 and 2021.

Pluxee shares rose 2% following a reaffirmed buy recommendation from Kepler Cheuvreux despite a new antitrust investigation in Chile.

Pluxee is facing a legal claim from the Chilean Competition Authority regarding alleged anticompetitive conduct in the employee benefits sector between 2013 and 2021.

Chile's competition authority is investigating Pluxee for alleged anti-competitive practices in the employee benefits market between 2013 and 2021.

Pluxee's Chilean subsidiary is facing a competition claim filed by the national regulatory authority.

Chilean antitrust regulators are investigating Pluxee for alleged anti-competitive practices in the employee benefits market between 2013 and 2021.

Chilean antitrust authorities have launched a legal challenge against Pluxee and Edenred for alleged anti-competitive behavior in the employee benefits market.